SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-19-075212
Filing Date
2019-12-23
Accepted
2019-12-20 20:22:25
Documents
4
Group Members
KOH, BONGSHAH, NIMISHVENROCK HEALTHCARE CAPITAL PARTNERS III, L.P.VHCP CO-INVESTMENT HOLDINGS II, LLCVHCP CO-INVESTMENT HOLDINGS III, LLCVHCP MANAGEMENT II, LLCVHCP MANAGEMENT III, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G a19-26407_1sc13g.htm SC 13G 314431
2 EX-99.A a19-26407_1ex99da.htm EX-99.A 31648
3 EX-99.B a19-26407_1ex99db.htm EX-99.B 8494
4 EX-99.C a19-26407_1ex99dc.htm EX-99.C 8490
  Complete submission text file 0001104659-19-075212.txt   364948
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Subject) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90033 | Film No.: 191303257
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7 BRYANT PARK 23RD FLOOR NEW YORK NY 10018
Business Address 7 BRYANT PARK 23RD FLOOR NEW YORK NY 10018 650 475 3734
Venrock Healthcare Capital Partners II, L.P. (Filed by) CIK: 0001602264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G